Shanghai Pharmaceuticals Holding Co Ltd (601607) — Financial Flexibility Index
Shanghai Pharmaceuticals Holding Co Ltd (601607) has a Financial Flexibility Index of 0.01x as of September 2025. Free cash flow of CN¥2.05 Billion (operating CF CN¥1.56 Billion minus capex CN¥487.63 Million) represents 0% of total liabilities (CN¥147.12 Billion). Check how strategically is Shanghai Pharmaceuticals Holding Co Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Shanghai Pharmaceuticals Holding Co Ltd Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for Shanghai Pharmaceuticals Holding Co Ltd across 28 annual periods. See working capital to net assets of Shanghai Pharmaceuticals Holding Co Ltd to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Shanghai Pharmaceuticals Holding Co Ltd (1998–2025)
Year-by-year free cash flow to debt coverage for Shanghai Pharmaceuticals Holding Co Ltd. For the full company profile including market capitalisation, see market cap of Shanghai Pharmaceuticals Holding Co Ltd.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.06x | CN¥8.48 Billion | CN¥6.15 Billion | CN¥143.36 Billion | ▼ -1.2% |
| 2024 | 0.06x | CN¥8.23 Billion | CN¥5.83 Billion | CN¥137.47 Billion | ▼ -3.9% |
| 2023 | 0.06x | CN¥8.20 Billion | CN¥5.23 Billion | CN¥131.65 Billion | ▲ +0.8% |
| 2022 | 0.06x | CN¥7.43 Billion | CN¥4.74 Billion | CN¥120.13 Billion | ▼ -29.7% |
| 2021 | 0.09x | CN¥9.18 Billion | CN¥5.06 Billion | CN¥104.37 Billion | ▼ -15.7% |
| 2020 | 0.10x | CN¥9.85 Billion | CN¥6.84 Billion | CN¥94.44 Billion | ▲ +4.2% |
| 2019 | 0.10x | CN¥8.78 Billion | CN¥6.02 Billion | CN¥87.64 Billion | ▲ +58.6% |
| 2018 | 0.06x | CN¥5.08 Billion | CN¥3.14 Billion | CN¥80.45 Billion | ▼ -25.9% |
| 2017 | 0.09x | CN¥4.66 Billion | CN¥2.65 Billion | CN¥54.67 Billion | ▼ -3.8% |
| 2016 | 0.09x | CN¥4.07 Billion | CN¥1.95 Billion | CN¥45.91 Billion | ▲ +17.0% |
| 2015 | 0.08x | CN¥3.07 Billion | CN¥1.35 Billion | CN¥40.54 Billion | ▼ -4.2% |
| 2014 | 0.08x | CN¥2.63 Billion | CN¥1.34 Billion | CN¥33.24 Billion | ▲ +14.9% |
| 2013 | 0.07x | CN¥1.88 Billion | CN¥973.45 Million | CN¥27.31 Billion | ▼ -13.6% |
| 2012 | 0.08x | CN¥1.86 Billion | CN¥1.15 Billion | CN¥23.37 Billion | ▼ -21.0% |
| 2011 | 0.10x | CN¥2.19 Billion | CN¥1.77 Billion | CN¥21.69 Billion | ▼ -26.6% |
| 2010 | 0.14x | CN¥2.24 Billion | CN¥1.69 Billion | CN¥16.28 Billion | ▲ +16.9% |
| 2009 | 0.12x | CN¥744.10 Million | CN¥664.13 Million | CN¥6.33 Billion | ▲ +76.9% |
| 2008 | 0.07x | CN¥376.18 Million | CN¥285.68 Million | CN¥5.67 Billion | ▼ -49.6% |
| 2007 | 0.13x | CN¥681.23 Million | CN¥488.94 Million | CN¥5.17 Billion | ▼ -17.3% |
| 2006 | 0.16x | CN¥734.71 Million | CN¥583.11 Million | CN¥4.61 Billion | ▲ +156.8% |
| 2005 | 0.06x | CN¥271.09 Million | CN¥73.00 Million | CN¥4.37 Billion | ▼ -13.6% |
| 2004 | 0.07x | CN¥316.05 Million | CN¥61.66 Million | CN¥4.40 Billion | ▲ +70.0% |
| 2003 | 0.04x | CN¥170.07 Million | CN¥484.27K | CN¥4.03 Billion | ▼ -62.2% |
| 2002 | 0.11x | CN¥380.28 Million | CN¥100.84 Million | CN¥3.40 Billion | ▲ +31.4% |
| 2001 | 0.09x | CN¥210.44 Million | CN¥65.73 Million | CN¥2.47 Billion | ▼ -24.5% |
| 2000 | 0.11x | CN¥287.31 Million | CN¥146.22 Million | CN¥2.55 Billion | ▲ +14.4% |
| 1999 | 0.10x | CN¥217.15 Million | CN¥164.67 Million | CN¥2.21 Billion | ▲ +265.0% |
| 1998 | -0.06x | CN¥-113.25 Million | CN¥-283.14 Million | CN¥1.90 Billion | — |